Sign inJoin waitlistJoin the waitlist

AY

Anthony Yu

Associate Attending Physician · New York Presbyterian Hospital

Credentials: · · · · · ·

History

New York Presbyterian Hospital
Present

Mount Sinai Hospital
2010–2013
Hospital of the University of Pennsylvania
2007–2010
Cornell University
Harvard Medical School
2003–2007

Research

Obesity As a Risk Factor for Anthracyclines and Trastuzumab Cardiotoxicity in Breast Cancer: A Systematic Review and Meta-Analysis
Systematic review or meta-analysis · Journal of Clinical Oncology · 2016 · 172 citations
Exercise and Risk of Cardiovascular Events in Women With Nonmetastatic Breast Cancer
Journal of Clinical Oncology · 2016 · 141 citations
Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt study
Breast Cancer Research and Treatment · 2019 · 114 citations

Richard Steingart
29 papers
CD
Chau Dang
28 papers
JL
Jennifer Liu
26 papers
Kevin Oeffinger
10 papers
CH
Clifford Hudis
7 papers
CC
Carol Chen
6 papers
Ana Barac
4 papers
HL
Heather Landau
4 papers
JY
Ji Yang
4 papers · 1 as a fellow
Mohammed Al-Sadawi
4 papers · 4 as a fellow
RC
Robert Copeland-Halperin
4 papers · 2 as a fellow
BM
Beryl McCormick
3 papers

Grants

Intensive Blood Pressure Control During Cardiotoxic Breast Cancer Treatment (PROTECT) Trial
National Cancer Institute · R37
Contact PI · $2.3M · Sloan-Kettering Inst Can Research
2023–2028
Effects of Exercise on Changes in Cardiovascular Biomarkers in Patients with Breast Cancer During Anthracycline-Based Chemotherapy
National Cancer Institute · R03
Contact PI · $177K · Sloan-Kettering Inst Can Research
2023–2024
Enhancing Understanding of Harms and Benefits of Cardiac Monitoring During Breast Cancer Therapy
National Cancer Institute · K23
Contact PI · $879.6K · Sloan-Kettering Inst Can Research
2017–2023

Clinical trials

A Study of Blood Pressure Control During Cancer Treatment
Principal investigator · Recruiting · Phase 2
Memorial Sloan Kettering Cancer Center
2023–2029
A Study of Vericiguat in People With Breast Cancer and Cancer Therapy-Related Cardiac Dysfunction
Principal investigator · Active not recruiting · Phase 2
Memorial Sloan Kettering Cancer Center
2023–2028
Study of Cardiopulmonary Exercise Testing in Women Who Have HER2-Positive Breast Cancer With Mild Cardiotoxicity
Principal investigator · Active not recruiting
Memorial Sloan Kettering Cancer Center
2021–2026
A Study of Limited Heart Monitoring During Non-anthracycline Trastuzumab-based Therapy in Breast Cancer Patients
Principal investigator · Active not recruiting
Memorial Sloan Kettering Cancer Center
2019–2027